Epidermal growth factor receptor (EGFR) expression in high grade glioma and relationship with histopathologic findings, a cross sectional study

[1]  Jong-Won Kim,et al.  Clinical Practice Guidelines for Pre-Analytical Procedures of Plasma Epidermal Growth Factor Receptor Variant Testing , 2022, Annals of laboratory medicine.

[2]  H. Tabriz,et al.  Relationship between phosphatase and tensin homolog (PTEN) expression in high grade glioma and histopathologic findings , 2021, Romanian Journal of Neurology.

[3]  Q. Ji,et al.  Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies , 2021, Journal of experimental & clinical cancer research : CR.

[4]  Chengwei He,et al.  Drug resistance of targeted therapy for advanced non-small cell lung cancer harbored EGFR mutation: from mechanism analysis to clinical strategy , 2021, Journal of Cancer Research and Clinical Oncology.

[5]  Vikram Singh,et al.  Epidermal growth factor receptor inhibitors as potential anticancer agents: An update of recent progress. , 2021, Bioorganic chemistry.

[6]  P. Bradley,et al.  STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery , 2021, Annals of medicine and surgery.

[7]  V. Puduvalli,et al.  Prognostic implications of epidermal and platelet-derived growth factor receptor alterations in 2 cohorts of IDHwt glioblastoma , 2021, Neuro-oncology advances.

[8]  M. Jinga,et al.  Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now? , 2021, International journal of molecular sciences.

[9]  M. J. Ramaiah,et al.  mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme , 2021, Molecular Biology Reports.

[10]  R. Magge,et al.  Mechanisms of EGFR Resistance in Glioblastoma , 2020, International journal of molecular sciences.

[11]  M. Khasraw,et al.  Anti-epidermal growth factor receptor therapy for glioblastoma in adults. , 2019, The Cochrane database of systematic reviews.

[12]  D. Mehrabani,et al.  Evaluation of VEGF, FGF and PDGF and Serum Levels of Inflammatory Cytokines in Patients with Glioma and Meningioma in Southern Iran , 2019, Asian Pacific journal of cancer prevention : APJCP.

[13]  H. Saffar,et al.  The Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis , 2019, International journal of hematology-oncology and stem cell research.

[14]  Y. Hirose,et al.  World Health Organization grade II–III astrocytomas consist of genetically distinct tumor lineages , 2016, Cancer science.

[15]  T. Gupta,et al.  Epidermal growth factor receptor (EGFR) gene amplification in high-grade gliomas: Western Indian tertiary cancer center experience. , 2016, Neurology India.

[16]  R. Roskoski.  The ErbB/HER family of protein-tyrosine kinases and cancer. , 2014, Pharmacological research.

[17]  M. Ladanyi,et al.  Immunohistochemical staining with EGFR mutation-specific antibodies: high specificity as a diagnostic marker for lung adenocarcinoma , 2013, Modern Pathology.

[18]  B. Jarzab,et al.  Epidermal growth factor receptor gene expression in high grade gliomas. , 2011, Folia neuropathologica.

[19]  S. Ghodsi,et al.  Epidemiologic patterns of primary brain tumors in Iran. , 2008, Asian Pacific journal of cancer prevention : APJCP.

[20]  J. Isola,et al.  Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival , 2006, Neuropathology and applied neurobiology.

[21]  A. Korshunov,et al.  The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years , 2005, Cancer.

[22]  M. Alonso,et al.  Molecular analysis of the EGFR gene in astrocytic gliomas: mRNA expression, quantitative‐PCR analysis of non‐homogeneous gene amplification and DNA sequence alterations , 2005, Neuropathology and applied neurobiology.

[23]  D. Louis,et al.  Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma , 2004, Clinical Cancer Research.

[24]  B. Zoll,et al.  Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis , 1995, Journal of Neurology.

[25]  Kenji Tada,et al.  Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. , 2003, Cancer research.

[26]  Fang Tan,et al.  The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  C. James,et al.  PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. , 2001, Journal of the National Cancer Institute.

[28]  M. C. Lee,et al.  p53 mutation and epidermal growth factor receptor overexpression in glioblastoma. , 2001, Journal of Korean medical science.

[29]  R. Fimmers,et al.  Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas. , 1996, Journal of neurosurgery.

[30]  M Kiessling,et al.  Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastoma , 2007, International journal of cancer.